Adipotide (Prohibitin-TP01) / Arrowhead - LARVOL DELTA

A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity (clinicaltrials.gov) - P1; N=4; Terminated; Sponsor: M.D. Anderson Cancer Center; Trial completion date: May 2020 ➔ Jan 2019; Active, not recruiting ➔ Terminated; Trial primary completion date: May 2019 ➔ Jan 2019; Terminated per PI's request

Clinical • Trial completion date • Trial primary completion date • Trial termination • Genetic Disorders • Genito-urinary Cancer • Obesity • Oncology • Prostate Cancer • Solid Tumor

A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity (clinicaltrials.gov) - P1; N=4; Active, not recruiting; Sponsor: M.D. Anderson Cancer Center; Trial primary completion date: May 2018 ➔ May 2019

Trial primary completion date • Biosimilar • Genito-urinary Cancer • Obesity • Oncology • Prostate Cancer • Solid Tumor